European Medicines Agency recommends against combining RAS-acting drugs

  • April 20, 2014

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee has issued a recommendation against the combined use of different classes of medications acting on the renin-angiotensin system.

The drug classes mentioned in the recommendation include angiotensin receptor blockers, ACE inhibitors and direct renin inhibitors, according to a press release.

Full Story »

More »
  • Health Care Update
  • PQRS interim claims
  • 2013 PQRS interim claims feedback data now available for individual eligible professionals. Analysis by Catherine Brandon of Arnold & Porter LLP.
More »
  • Blog
  • Editor Pick 2
  • Eye on Intervention
  • Stephen P. Hoole, MA, discusses whether consent procedures for STEMI trials should be reviewed.
More »
More »
More »
More »

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!